Medication Exposure Definitions in Perinatal Pharmacoepidemiology: Implications for Pregnancy Studies

BACKGROUND: Exposure definitions in real-world pregnancy studies vary across studies, data sources, treatments and outcomes, yet their impact on prevalence estimates remains unexamined. OBJECTIVES: To identify the most used exposure definitions during the 1st trimester and evaluate their impact on prevalence estimates: METHODS: We reviewed 400 randomly selected articles on medication use during pregnancy to identify exposure definitions. Using Danish health registers (1997-2024) and the Québec Pregnancy Cohort (1998-2015), we analysed chronic, as-needed, and acute medication use. Prevalence (per 1000) was calculated per definition, including: (1) ≥ 1 or (2) ≥ 2 filled prescriptions during 1st trimester; filled ≥ 1 prescription anytime between the 1st trimester or (3) 30 days, (4) 60 days, (5) 90 days, (6) 6 months before conception; filled a prescription during 1st trimester or before conception, (7) assuming 1 daily defined dose per day or (8) prescribed days overlapping 1st trimester. Trends across cohorts and medications were compared. RESULTS: We analysed 1,524,075 pregnancies in Denmark and 229,000 in Québec, Canada. The most common exposure definitions identified from the literature were Definition 1 (83%), followed by Definition 3 (13%). Prevalence varied across definitions, with differential impacts depending on medication and type of use. Definition 6 (1st trimester or within the 6 months before conception) yielded the highest prevalence; Definition 2 (≥ 2 fills in 1st trimester) the lowest. Broader time-windows of exposure increased prevalence, with variation by medication. The prevalence of medication use, whether chronic or acute, showed less variation across definitions than that of as-needed medication. CONCLUSIONS: Medication exposure prevalence varied by definition and medication. Using ≥ 1 filled prescriptions in the 1st trimester yielded prevalence estimates comparable to those from more complex definitions, supporting its use as a pragmatic standard. Sensitivity analyses and transparent reporting of exposure definition are essential to ensure replicability and critical appraisal.

Authors

Institutions

Publication Details

Journal
Paediatric and Perinatal Epidemiology
Published
2026-05-29
DOI
https://doi.org/10.1111/ppe.70158
Primary Topic
Pregnancy and Medication Impact
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Medication Exposure Definitions in Perinatal Pharmacoepidemiology: Implications for Pregnancy Studies

Mette Bliddal, Anton Pottegård, Gabra Nohmie, Anick Bérard
Paediatric and Perinatal Epidemiology
Pregnancy and Medication Impact
article

Medication Exposure Definitions in Perinatal Pharmacoepidemiology: Implications for Pregnancy Studies

Mette Bliddal, Anton Pottegård, Gabra Nohmie, Anick Bérard
article en

Abstract

BACKGROUND: Exposure definitions in real-world pregnancy studies vary across studies, data sources, treatments and outcomes, yet their impact on prevalence estimates remains unexamined. OBJECTIVES: To identify the most used exposure definitions during the 1st trimester and evaluate their impact on prevalence estimates: METHODS: We reviewed 400 randomly selected articles on medication use during pregnancy to identify exposure definitions. Using Danish health registers (1997-2024) and the Québec Pregnancy Cohort (1998-2015), we analysed chronic, as-needed, and acute medication use. Prevalence (per 1000) was calculated per definition, including: (1) ≥ 1 or (2) ≥ 2 filled prescriptions during 1st trimester; filled ≥ 1 prescription anytime between the 1st trimester or (3) 30 days, (4) 60 days, (5) 90 days, (6) 6 months before conception; filled a prescription during 1st trimester or before conception, (7) assuming 1 daily defined dose per day or (8) prescribed days overlapping 1st trimester. Trends across cohorts and medications were compared. RESULTS: We analysed 1,524,075 pregnancies in Denmark and 229,000 in Québec, Canada. The most common exposure definitions identified from the literature were Definition 1 (83%), followed by Definition 3 (13%). Prevalence varied across definitions, with differential impacts depending on medication and type of use. Definition 6 (1st trimester or within the 6 months before conception) yielded the highest prevalence; Definition 2 (≥ 2 fills in 1st trimester) the lowest. Broader time-windows of exposure increased prevalence, with variation by medication. The prevalence of medication use, whether chronic or acute, showed less variation across definitions than that of as-needed medication. CONCLUSIONS: Medication exposure prevalence varied by definition and medication. Using ≥ 1 filled prescriptions in the 1st trimester yielded prevalence estimates comparable to those from more complex definitions, supporting its use as a pragmatic standard. Sensitivity analyses and transparent reporting of exposure definition are essential to ensure replicability and critical appraisal.

Paediatric and Perinatal Epidemiology
University of Southern Denmark (DK), Odense University Hospital (DK), Centre Hospitalier Universitaire Sainte-Justine (CA), Université de Montréal (CA)
Good health and well-being
Openalex Percentile: Top 5%
Pregnancy and Medication Impact
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.